skip to content

Cambridge Cardiovascular

 

Cell & Gene Therapy: from Plasmid to Therapy

Seminar delivered by Dr Ian Pringle

Viral Vector Production from Bench to Clinic (15 m)
- Overview of suspension culture systems for LV and AAV production
How to make plasmids for Cell & Gene Therapy (30 m)
- Overview of regulatory requirements for plasmid design
- Benefits of modular plasmid construction
- Simple plasmid design and construction with GeneArt
General Discussion (15 m)

Dr Ian Pringle has over 20 years’ experience in the field of Gene and Cell Therapy. Previously he worked for the UK Cystic Fibrosis Gene Therapy Consortium (UKCFGTC). He had a leading role in the development of the Consortium’s non-viral gene therapy programme for Cystic Fibrosis lung disease. This work led in part to the Consortium’s successful multi dose clinical trial published in 2015. He has also worked in the biotech sector, developing lentiviral production and purification processes for CAR-T cell therapy.

You can Register here

Followed by Pizza

Date: 
Tuesday, 24 October, 2023 - 12:00 to 13:00
Event location: 
Theatre Room, CRUK, Addenbrooke's Campus, University of Cambridge

Cambridge Cardiovascular logo - transparent

We connect cardiovascular researchers in Cambridge and beyond.

For inquiries about our research, please contact Dr Jane Sugars

For enquiries about our website or joining Cambridge Cardiovascular, please contact Denise Hatherly

Find us on LinkedIn

 

Follow us on X

Please follow us here on X for local news about research, events, funding calls, and open positions.

You must be logged into X to see our feed here:

Our Newsletter


             Subscribe here

        Previous Newsletters

 

Find us on YouTube